Statistics for Mrna vaccines against sars-cov-2: advantages and caveats
Total visits
views | |
---|---|
Mrna vaccines against sars-cov-2: advantages and caveats | 92 |
Total visits per month
views | |
---|---|
March 2025 | 1 |
April 2025 | 0 |
May 2025 | 2 |
June 2025 | 0 |
July 2025 | 0 |
August 2025 | 0 |
September 2025 | 0 |
File Visits
views | |
---|---|
Echaide_mRNAVaccines.pdf | 206 |
Top country views
views | |
---|---|
United States | 50 |
Sweden | 4 |
Spain | 3 |
Japan | 3 |
Malaysia | 3 |
Saudi Arabia | 3 |
Canada | 2 |
China | 2 |
Italy | 2 |
South Korea | 2 |
Singapore | 2 |
Ethiopia | 1 |
Israel | 1 |
India | 1 |
Kazakhstan | 1 |
Taiwan | 1 |
Top city views
views | |
---|---|
Oakland | 16 |
Ann Arbor | 5 |
San Diego | 5 |
Mountain View | 3 |
Bartlesville | 2 |
Beijing | 2 |
Kuala Lumpur | 2 |
New York | 2 |
Singapore | 2 |
Tempe | 2 |
Umeå | 2 |
Asheville | 1 |
Chatham | 1 |
Irvine | 1 |
Jacksonville | 1 |
Jerusalem | 1 |
Kyoto | 1 |
Leawood | 1 |
London | 1 |
Madrid | 1 |
Menlo Park | 1 |
New Port Richey | 1 |
Portland | 1 |
Salt Lake City | 1 |
Seoul | 1 |
Sevilla | 1 |
Stanford | 1 |
Tokyo | 1 |
Wilmington | 1 |